Liang Zhao
No ORCID on file
· 8 papers in corpus
· active 2021-2025
Study types
- article 2
- meta-analysis 1
- preprint 1
- review 1
Condition tags
- endometriosis 3
- mesh:D004715 2
- adenomyosis 2
Top journals
Frequent coauthors
- Lu Liu 2
- Yi Hao 2
- Kanako Hayashi 2
- Dongmei Lin 2
- Mingxin Shi 2
- Sarayut Winuthayanon 2
- James A. MacLean 2
- Hongyan Tian 2
- Hui Wang 2
- H. Y. Cheng 1
2025
article
2024
FUAS is safe and effective for the treatment of abdominal wall endometriosis, which has clinical application value.
2023
review
2023
OBJECTIVE: To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation. DATA SOUR…
meta-analysis
2023
OBJECTIVE: To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation. DATA SOU…
preprint
2022
Abstract Due to the vital roles of macrophages in the pathogenesis of endometriosis, targeting macrophages could be a new therapeutic direction. Here, we investigated the efficacy of niclosamide for the resolution of perturbed microenvironm…
article
2022
Due to the vital roles of macrophages in the pathogenesis of endometriosis, targeting macrophages could be a promising therapeutic direction. Here, we investigated the efficacy of niclosamide for the resolution of a perturbed microenvironme…
2021